Navidea Biopharmaceuticals Inc. has removed a stock incentive plan …
stock bonus
As mentioned above, Navidea Biopharmaceuticals is having a strong day in the market today after announcing that it has executed a Letter of Intent. The LOI was executed with Cardinal Health, Inc. (NYSE: CAH). …
Stock
While incredibly volatile, Navidea Biopharmaceuticals has been trending up overall in the market as of late, and for good reason. The company recently sold a core asset that, which got rid of debt and gave the company the …
Reason
Navidea Biopharmaceuticals, Inc (NYSEMKT ... Corporation and gave the company a "buy" rating in a research report on Friday, September …
Anadarko Petroleum
This is a momentum stock rating analysis for Navidea Biopharmaceuticals, Inc (AMEX:NAVB) . The company has a one bull momentum rating which indicates extreme weakness. While the value investor may see an …
Stock
05/03/2015 – Navidea Biopharmaceuticals, Inc. had its “buy” rating reiterated by analysts at Zacks. They now have a USD 2 price target on the stock. 10/15/2014 – Navidea Biopharmaceuticals, Inc. had its “positive” …
As you can see from the stock charts, something good happened to NAVB, as the stock has rallies from a low of $0.26 to over a dollar, depending on which day you're looking at. So what happened? The struggle of 2016 for …
Seeking Alpha
Navidea Biopharmaceuticals, Inc NAVB was a big mover last session, as the company saw its shares rise around 6% on the day. The move came on solid volume too with far more shares changing hands than in a …
Navidea Biopharmaceuticals, Inc (NAVB) down -3.02 per cent in the past week, is under coverage of 1 …